NSE: TAKE

Take Ltd Share Price

Company information and financial fundamentals for Take Ltd, alongside its latest NSE share price.

Last price₹11.99+12.48% today · prev close ₹10.66
SectorHealthcare

About Take Ltd

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Classification: Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology · NSE symbol: TAKE

Company fundamentals

Market Cap₹ 177 Cr.
Current Price₹ 12.0
High / Low₹ 50.1 / 9.83
Stock P/E29.9
Book Value₹ 2.10
Dividend Yield0.00 %
ROCE18.5 %
ROE16.5 %
Face Value₹ 1.00

Figures are as reported by the company and compiled by screener.in (fetched 2026-11-05); they may lag the latest filing. Educational information, not investment advice.

Quarterly results (₹ crore)

Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.000.000.000.000.000.000.000.0054.1930.37
YoY Sales growth-100.00%-100.00%-100.00%———————
Expenses15.762.220.902.891.150.440.300.3555.0130.64
Operating Profit-15.76-2.22-0.90-2.89-1.15-0.44-0.30-0.35-0.82-0.27
OPM %————————-1.51%-0.89%
Other Income-93.70-0.97-0.2351.31-3.48-0.296.921.465.181.33
Interest0.540.490.500.730.240.180.170.000.000.00
Depreciation0.010.010.010.010.010.000.000.000.000.00
Profit before tax-110.01-3.69-1.6447.68-4.88-0.916.451.114.361.06
Tax %0.55%1.63%-3.66%0.00%0.00%0.00%2.48%0.00%0.00%0.00%
Net Profit-110.61-3.75-1.5847.68-4.88-0.916.291.114.361.06
EPS in Rs-7.48-0.25-0.113.22-0.33-0.060.430.080.290.07
Raw PDF——————————

Profit and loss, yearly (₹ crore)

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,5872,0392,213774655189405485
Sales growth+18%+28%+9%-65%-15%-71%-98%-100%——
Expenses1,2811,6552,0448476482082475686
Operating Profit307384169-737-19-20-7-2-2
OPM %19%19%8%-9%1.1%-10%-569%—-3.5%-2.1%
Other Income61126-211-677-56-92471315
Interest212541372972200
Depreciation10415416711580171000
Profit before tax188216-13-437-779-99-116371113
Tax %15%17%-15%3%0%2%3%0%1%—
Net Profit160178-11-450-782-100-120371113
EPS in Rs10.8511.99-0.84-30.56-52.88-6.78-8.092.530.730.87
Dividend Payout %15%8%0%0%0%0%0%0%0%—

Compounded growth

Compounded Sales Growth10 Years -26%5 Years -41%3 Years -34%TTM %
Compounded Profit Growth10 Years -27%5 Years 15%3 Years 27%TTM 80%
Stock Price CAGR10 Years -22%5 Years -25%3 Years -16%1 Year -50%
Return on Equity10 Years -10%5 Years -104%3 Years -47%Last Year 17%

Balance sheet (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital13151515151515151515
Reserves8981,3141,5041,5611,11016694-24616
Borrowings23732347455351459463700
Other Liabilities2211893393361879846960165
Total Liabilities1,3691,8402,3312,4651,8261,223224883636
Fixed Assets5545891,0911,234934101733000
CWIP21424110311000
Investments10591018700000
Other Assets7851,1501,1881,2138851,119140583636
Total Assets1,3691,8402,3312,4651,8261,223224883636

Cash flows (₹ crore)

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5612110421113530209-16-4
Cash from Investing Activity-130-179-474-233-5715-3-7222
Cash from Financing Activity5630210021-84-55-36-12-3-1
Net Cash Flow-18243-270-2-6-10-18-103-3
Free Cash Flow-3039-2354133-2-122-16-4
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit26%44%30%156%-212%704%-114%-43%217%208%

Efficiency ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days118108941162054558715—1
Inventory Days—————————0
Days Payable——————————
Cash Conversion Cycle118108941162054558715—1
Working Capital Days9085678014028-42-5,559—123
ROCE %17%15%13%1%-9%-6%-14%-22%11%19%

Shareholding pattern (%)

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters53.41%53.41%53.41%53.41%53.34%5.19%0.00%0.00%0.00%0.00%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.56%0.28%0.20%0.21%
DIIs0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Public46.58%46.58%46.59%46.58%46.65%94.81%99.44%99.73%99.80%99.79%
No. of Shareholders80,28878,03377,16375,98875,14174,41070,32464,69963,21363,302

Exchange disclosures

Next results date

Take Ltd has a board meeting for financial results listed on 2026-11-13. Companies can reschedule; check the company's own announcement. Results calendar

Shown as filed with NSE. A filing shows that something happened, not why, and says nothing about what to do.

Compare TAKE with APOLLOHOSP →

Wondering what to do with Take Ltd?

This page shares company information and reported fundamentals. It does not tell you whether to buy, hold or sell. For a view that takes your own holding and goal into account, ask Samjho Bhai, our portfolio review tool.

Ask Samjho Bhai about TAKE →

How this page works · New to company fundamentals? Start learning.

Key terms: Nifty 50 · Price-to-earnings ratio · Earnings per share · Dividend yield · Market capitalisation

Other Healthcare stocks in the NSE

Apollo HospitalsNSE: APOLLOHOSPCiplaNSE: CIPLADr. Reddy's LaboratoriesNSE: DRREDDYMax HealthcareNSE: MAXHEALTHSun PharmaNSE: SUNPHARMA

Frequently asked questions

What is the NSE symbol for Take Ltd?

Take Ltd trades on the NSE under the symbol TAKE.

Where is Take Ltd listed?

Take Ltd is listed on the National Stock Exchange of India (NSE) under the symbol TAKE. It is not part of the NIFTY 50 or NIFTY 500 lists this site tracks.

Should I buy Take Ltd shares?

Market Dekho does not give buy, sell or hold recommendations and is not a SEBI-registered Research Analyst or Investment Adviser. To review a holding against your own goal and risk, you can use Samjho Bhai, or speak to a SEBI-registered adviser.

Prices are delayed and sourced from a public market-data provider; they may contain errors. This page is educational information, not investment advice.